A phase I study of neoadjuvant cisplatin (C), docetaxel (D) and nintedanib (N) for resectable non-small cell lung cancer (NSCLC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Tina Cascone, Boris Sepesi, Heather Y. Lin, Neda Kalhor, Jianjun Zhang, Frank V. Fossella, Anne S. Tsao, Vincent K. Lam, Charles Lu, Frank Mott, George R. Simon, Mara Antonoff, Reza J. Mehran, David C. Rice, Ara A. Vaporciyan, Myrna Godoy, J. Jack Lee, Stephen Swisher, William Nassib William, John Heymach
Institution: The University of Texas MD Anderson Cancer Center
Language: French
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890882505